Moderna Faces Challenges as Pandemic Eases
Moderna, which spearheaded development of the first vaccines for COVID-19, faces a challenging outlook as vaccination rates increase and infection rates fall.
Trending
Symbol | Last Price | Change | % Change |
---|---|---|---|